Gilman Hill Asset Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.34M | Sell |
10,457
-400
| -4% | -$46.8K | 0.18% | 107 |
|
|
2026
Q1 | $1.31M | Sell |
10,857
-370
| -3% | -$42.7K | 0.2% | 101 |
|
|
2025
Q4 | $1.18M | Buy |
11,227
+875
| +8% | +$82.1K | 0.19% | 104 |
|
|
2025
Q3 | $869K | Buy |
10,352
+14
| +0.1% | +$1.15K | 0.14% | 116 |
|
|
2025
Q2 | $818K | Sell |
10,338
-1,225
| -11% | -$97.4K | 0.13% | 122 |
|
|
2025
Q1 | $1.04M | Sell |
11,563
-309
| -3% | -$28.9K | 0.18% | 104 |
|
|
2024
Q4 | $1.18M | Sell |
11,872
-975
| -8% | -$101K | 0.21% | 104 |
|
|
2024
Q3 | $1.46M | Sell |
12,847
-396
| -3% | -$47K | 0.24% | 98 |
|
|
2024
Q2 | $1.64M | Buy |
13,243
+1,175
| +10% | +$151K | 0.3% | 91 |
|
|
2024
Q1 | $1.59M | Sell |
12,068
-86
| -0.7% | -$10.6K | 0.29% | 92 |
|
|
2023
Q4 | $1.33M | Sell |
12,154
-105
| -0.9% | -$10.9K | 0.25% | 99 |
|
|
2023
Q3 | $1.26M | Sell |
12,259
-5
| -0% | -$539 | 0.25% | 100 |
|
|
2023
Q2 | $1.42M | Buy |
12,264
+120
| +1% | +$13.6K | 0.26% | 99 |
|
|
2023
Q1 | $1.29M | Sell |
12,144
-789
| -6% | -$85.2K | 0.26% | 96 |
|
|
2022
Q4 | $1.43M | Sell |
12,933
-1,123
| -8% | -$115K | 0.29% | 92 |
|
|
2022
Q3 | $1.21M | Buy |
14,056
+704
| +5% | +$62.8K | 0.28% | 99 |
|
|
2022
Q2 | $1.22M | Sell |
13,352
-719
| -5% | -$63.7K | 0.26% | 95 |
|
|
2022
Q1 | $1.16M | Buy |
14,071
+1,036
| +8% | +$81.7K | 0.26% | 94 |
|
|
2021
Q4 | $999K | Sell |
13,035
-119
| -0.9% | -$9.48K | 0.22% | 103 |
|
|
2021
Q3 | $988K | Buy |
13,154
+561
| +4% | +$42.7K | 0.25% | 94 |
|
|
2021
Q2 | $979K | Buy |
12,593
+750
| +6% | +$55.8K | 0.25% | 93 |
|
|
2021
Q1 | $871K | Buy |
11,843
+81
| +0.7% | +$5.97K | 0.24% | 96 |
|
|
2020
Q4 | $918K | Buy |
11,762
+1,431
| +14% | +$109K | 0.3% | 84 |
|
|
2020
Q3 | $818K | Sell |
10,331
-168
| -2% | -$13.2K | 0.32% | 79 |
|
|
2020
Q2 | $775K | Buy |
10,499
+338
| +3% | +$25.4K | 0.31% | 85 |
|
|
2020
Q1 | $746K | Buy |
10,161
+262
| +3% | +$20.6K | 0.36% | 81 |
|
|
2019
Q4 | $859K | Sell |
9,899
-27
| -0.3% | -$2.22K | 0.28% | 91 |
|
|
2019
Q3 | $797K | Hold |
9,926
| – | – | 0.27% | 93 |
|
|
2019
Q2 | $794K | Buy |
9,926
+236
| +2% | +$18.1K | 0.27% | 91 |
|
|
2019
Q1 | $769K | Buy |
9,690
+524
| +6% | +$39.2K | 0.27% | 91 |
|
|
2018
Q4 | $668K | Sell |
9,166
-361
| -4% | -$25.5K | 0.28% | 87 |
|
|
2018
Q3 | $645K | Sell |
9,527
-1,397
| -13% | -$89K | 0.25% | 94 |
|
|
2018
Q2 | $633K | Buy |
10,924
+1,016
| +10% | +$57.3K | 0.26% | 92 |
|
|
2018
Q1 | $515K | Buy |
9,908
+535
| +6% | +$28.9K | 0.23% | 106 |
|
|
2017
Q4 | $503K | Buy |
9,373
+52
| +0.6% | +$2.88K | 0.2% | 113 |
|
|
2017
Q3 | $570K | Sell |
9,321
-2,035
| -18% | -$123K | 0.23% | 99 |
|
|
2017
Q2 | $694K | Sell |
11,356
-654
| -5% | -$39.8K | 0.3% | 80 |
|
|
2017
Q1 | $728K | Sell |
12,010
-5,505
| -31% | -$334K | 0.32% | 73 |
|
|
2016
Q4 | $984K | Sell |
17,515
-1,068
| -6% | -$62.5K | 0.36% | 49 |
|
|
2016
Q3 | $1.11M | Buy |
18,583
+2,547
| +16% | +$149K | 0.43% | 51 |
|
|
2016
Q2 | $882K | Sell |
16,036
-970
| -6% | -$51.6K | 0.36% | 56 |
|
|
2016
Q1 | $859K | Sell |
17,006
-1,284
| -7% | -$62.9K | 0.39% | 55 |
|
|
2015
Q4 | $922K | Sell |
18,290
-171
| -0.9% | -$8.62K | 0.45% | 49 |
|
|
2015
Q3 | $870K | Buy |
18,461
+95
| +0.5% | +$5.05K | 0.45% | 54 |
|
|
2015
Q2 | $998K | Buy |
18,366
+5
| +0% | +$280 | 0.47% | 53 |
|
|
2015
Q1 | $1.01M | Buy |
18,361
+41
| +0.2% | +$2.32K | 0.48% | 53 |
|
|
2014
Q4 | $993K | Hold |
18,320
| – | – | 0.5% | 54 |
|
|
2014
Q3 | $1.04M | Sell |
18,320
-1,104
| -6% | -$62K | 0.56% | 51 |
|
|
2014
Q2 | $1.07M | Buy |
19,424
+42
| +0.2% | +$2.29K | 0.56% | 51 |
|
|
2014
Q1 | $1.05M | Buy |
19,382
+4,701
| +32% | +$243K | 0.62% | 48 |
|
|
2013
Q4 | $701K | Buy |
14,681
+1,048
| +8% | +$47.9K | 0.46% | 51 |
|
|
2013
Q3 | $619K | Sell |
13,633
-4,213
| -24% | -$192K | 0.45% | 51 |
|
|
2013
Q2 | $791K | Buy |
+17,846
| New | +$797K | 0.58% | 49 |
|
Other funds holding MRK
ECSS
Gilman Hill Asset Management's MRK Position: Q2 2026 in Review
Gilman Hill Asset Management reduced its Merck (MRK) stake by 3.7% in Q2 2026, selling an estimated $46.8K and leaving 10,457 shares worth $1.34M. The position accounts for 0.18% of the portfolio, ranked #107.
Gilman Hill Asset Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.64M in Q2 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Gilman Hill Asset Management held 10,457 shares of Merck worth $1.34M as of Q2 2026.
- Gilman Hill Asset Management sold 400 Merck shares in Q2 2026, an estimated $46.8K.
- Merck made up 0.18% of Gilman Hill Asset Management's portfolio in Q2 2026, its #107 holding.
- Gilman Hill Asset Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
- Gilman Hill Asset Management's Merck position peaked at $1.64M in Q2 2024.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Gilman Hill Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.